DJIA 18,132.70 -81.72 -0.45%
NASDAQ 4,963.53 -24.36 -0.49%
S&P 500 2,104.50 -6.24 -0.30%
market minute promo

ACTAVIS (NYSE: ACT)

291.36 1.58 (0.55%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

ACT $291.36 0.55%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $290.10
Previous Close $289.78
Daily Range $289.86 - $292.62
52-Week Range $184.71 - $296.77
Market Cap $77.6B
P/E Ratio -39.05
Dividend (Yield) $0.00 (0.0%)
Volume 3,747,249
Average Daily Volume 3,113,540
Current FY EPS $17.09

Sector

Healthcare

Industry

Drug Makers

ACTAVIS (ACT) Description

The Company is engaged in the development, manufacture, marketing, sale and distribution of brand and off-patent pharmaceutical products. Website: http://www.actavis.com/

News & Commentary

Billionaire George Soros Just Bought These 3 Stocks: Should You?

Hedge fund guru George Soros gobbled up these three healthcare stocks in the fourth-quarter. Should average investors follow in his footsteps?

The Best Scoring Stocks To Buy Now

Actavis' contraceptive device wins U.S. FDA approval

Actavis' Infectious Disease Product, Avycaz, Gets FDA Nod - Analyst Blog

Play This "Hidden" M&A Boom – and Beat the Market for the Next Two Years

UPRO, ACT, ADBE, ADT: Large Outflows Detected at ETF

Actavis' superbug antibiotic gets U.S. approval

Pre-Market Most Active for Feb 25, 2015 : PBR, PBR/A, HPQ, ACT, LL, HTZ, AAPL, TVIX, FSLR, CRIS, QQ

Pre-Market Most Active for Feb 25, 2015 : PBR, PBR/A, HPQ, ACT, LL, HTZ, AAPL, TVIX, FSLR, CRIS, QQQ, SIRI

Lannett Joins Big-Game Hunt For Drugmaker Acquisitions

3 Stocks Dragging The Drugs Industry Downward

Valeant Pharma (VRX) Soars on Salix Buy: 3 Keys for Investors - Stocks in the News

See More ACT News...

ACT's Top Competitors

ACT $291.36 (0.55%)
Current stock: ACT
JNJ $102.51 (-0.28%)
Current stock: JNJ
NVS $102.40 (-0.58%)
Current stock: NVS
RHHBY $34.13 (0.80%)
Current stock: RHHBY